Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001714899-23-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-02-10 | 2023-02-08 | DNLI | Schuth Alexander O. | COFO, Sec | S - Sale | $30.89 | -1,521 | 499.9K | -0.3% | -$47.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-08 | S | D | 1,521 | $30.89 | 499,902 | I See footnote | — | — | (F2) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.78 to $31.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F3) Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 4,250 RSUs held by the Reporting Person. (F4) The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. |